A Single Arm, Multi-Center Phase II Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma After Failure of Prior Platin-Based Chemotherapy.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 25 Mar 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

26 Sep 2012 New source identified and integrated (DRKS00004017: German Clinical Trials Register).
02 Aug 2012 Planned end date changed from 1 Dec 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
01 Mar 2012 Actual patient number (28) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com